FDA Approves Merilog as Biosimilar to Insulin Aspart for Diabetes
Drug Topics
FEBRUARY 14, 2025
The drug is the first rapid-acting insulin biosimilar product approved for use by the FDA, marking a significant milestone in diabetes treatment.
Fri.Feb 14, 2025
346 
STAT+: U.K. lawmaker wants regulators to probe pharma companies over ‘misleading’ Covid-19 vaccines statements
STAT
FEBRUARY 14, 2025
A member of the U.K. Parliament is calling for regulators to audit pharmaceutical companies that have made misleading statements to the public about their Covid-19 vaccines. And the move comes after Moderna was chastised for the second time in five months by a U.K. trade group over its attempts to recruit children into a late-stage clinical trial for its Covid shot.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Learning Sessions, Shared Decision Making Could Help Increase Vaccinations Among Older Adults
Drug Topics
FEBRUARY 14, 2025
Among providers who took part in a recent study, 57% reported increased vaccination rates after implementing a quality improvement initiative.
STAT+: Corbus reports first Western data for closely tracked ADC cancer drug
STAT
FEBRUARY 14, 2025
Corbus Pharmaceuticals on Friday presented new data from the first Western study of its antibody-drug conjugate treatment for cancer that largely mirrored previous results reported from China. In a study conducted in the U.S. and the U.K., the Corbus drug, called CRB-701, showed an overall response rate of 27% from 26 evaluable patients with nine different types of cancer — all in advanced stages.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Neuroactive Steroid Levels May Indicate Risk of Postpartum Depression
Drug Topics
FEBRUARY 14, 2025
Identifying women who are at risk for postpartum depression sooner can lead to quicker and possibly preventative treatment.
The view from overseas on tumult in U.S. science
STAT
FEBRUARY 14, 2025
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Happy V-Day! Gorge on heart-shaped chocolate and ponder the implications of RFK Jr. being sworn in as health secretary. Today, we talk about that, as well as new cancer data from Corbus Pharma, Europe’s reaction to talk of an academic brain drain in the U.S., and more.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Fierce Healthcare - Untitled Article
Fierce Healthcare
FEBRUARY 14, 2025
Editor's Note: This is a developing story. If you are a dismissed or active federal worker with information to share, please reach out at ntong@questex.com. | The federal government is laying off thousands of health agency workers and others this week. Here's what we know so far.
Pharmacists Educate and Bridge Communication Gaps for Patients With Pericarditis
Pharmacy Times
FEBRUARY 14, 2025
Pharmacists can help educate patients, identify adverse events, and help patients communicate with other health care professionals or drug companies.
Fierce Healthcare - Untitled Article
Fierce Healthcare
FEBRUARY 14, 2025
The dismissals will free up over $98 million annually which will be redirected to veterans' care, benefits and services, the department said. The cuts are part of the White House's broader directive to slash federal workforces.
Climate crisis and technological innovation shaping pharmaceutical water market
European Pharmaceutical Review
FEBRUARY 14, 2025
A report by Cervicorn Consulting forecasts that the pharmaceutical water market will value $96.25 billion by 2033, with a CAGR of 9.26 percent between 2024 and 2033. Key drivers include a rise in demand for high-quality water in the pharmaceutical industry, automation and government initiatives. The research suggests that during the forecast period, the market will emphasise addressing the challenges associated with limitations with manual monitoring processes and operational efficiencies.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Healthcare - Untitled Article
Fierce Healthcare
FEBRUARY 14, 2025
VoiceCare AI also started piloting its technology at Mayo Clinic to tackle patient pre-authorization and benefit confirmations within its neurology and pediatrics departments and medical and administrative support operations.
Study Finds Easy-to-Implement Treatment Strategy for Children With Peanut Allergy
Pharmacy Times
FEBRUARY 14, 2025
After gradually consuming increased doses of peanut butter, children who could initially tolerate about half a peanut could consume 3 tablespoons without an allergic reaction.
New evidence suggests bird flu in veterinarians went undetected
STAT
FEBRUARY 14, 2025
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Hi there! I’m Sarah — former Morning Rounds editor, current STAT reporter, and your friendly sub today.
Potential Drug for Mitigation of Cannabis Withdrawal Symptoms Receives FDA Fast Track Designation
Pharmacy Times
FEBRUARY 14, 2025
PP-01 could become a first-in-class treatment for patients with cannabis use disorder.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
RFK Jr-led commission will assess 'threats' to children
pharmaphorum
FEBRUARY 14, 2025
New HHS Secretary RFK Fr has been given the task of investigating child health in the US, including whether some medicines may pose a threat.
Rapid-Acting Insulin Biosimilar Receives FDA Approval for Diabetes
Pharmacy Times
FEBRUARY 14, 2025
Insulin-aspart-szjj (Merilog) is the first rapid-acting insulin biosimilar product approved by the FDA.
Apple study will look at the role tech can play in health
pharmaphorum
FEBRUARY 14, 2025
Apple has started a major new health study to see how devices like the iPhone, Apple Watch, and AirPods can be used to monitor and improve our health.
Enhancing Outcomes With Immunotherapy Agents for Patients With Non-Muscle Invasive Bladder Cancer
Pharmacy Times
FEBRUARY 14, 2025
Panelists at the 2025 ASCO Genitourinary Cancers Symposium discussed challenges and new approaches to treatment.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Newleos secures $93.5m for neuropsychiatric treatments
Pharmaceutical Technology
FEBRUARY 14, 2025
Newleos has closed an oversubscribed Series A financing round, raising $93.5m to revolutionise neuropsychiatric disorder treatments.
Educate Patients About First Aid Kit Essentials
Pharmacy Times
FEBRUARY 14, 2025
With a wealth of available nonprescription options, patients should know about various products and their uses.
EU reshapes HTAs: is the industry ready for it?
Pharmaceutical Technology
FEBRUARY 14, 2025
New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.
‘Off-Grid’ Electrical Activity Drives Tumor Growth in Small Cell Lung Cancer
Pharmacy Times
FEBRUARY 14, 2025
The cancer cells developed their own electrical network similar to neural behavior seen in the brain.
EU approves CSL's once-monthly HAE drug Andembry
pharmaphorum
FEBRUARY 14, 2025
The EU has approved CSL's once-monthly Andembry for hereditary angioedema, challenging therapies from Takeda and Biocryst
RSV in Older Adults: Risks, Prevention, and the Pharmacist's Role
Pharmacy Times
FEBRUARY 14, 2025
RSV poses a significant threat to high-risk adults, but effective vaccines offer strong protection, highlighting the need for increased vaccination rates and education.
BMS study of Opdualag in adjuvant melanoma ends in failure
pharmaphorum
FEBRUARY 14, 2025
Bristol Myers Squibb has reported disappointing results for its checkpoint inhibitor combination Opdualag in an adjuvant melanoma study.
Darolutamide Improved Survival in Phase 3 Trials for Patients With Metastatic Hormone-Sensitive Prostate Cancer
Pharmacy Times
FEBRUARY 14, 2025
The data were presented at the 2025 ASCO Genitourinary Cancers Symposium in San Francisco, California.
Taking the quantum leap: How life science real estate clusters accelerate innovation
pharmaphorum
FEBRUARY 14, 2025
Discover how life science real estate clusters drive innovation and collaboration, leading to groundbreaking advancements in the industry. Explore the impact of these clusters and how they propel progress in life sciences.
The Role of Pharmacists in Optimizing Care for Seizures in Neonatal Patients
Pharmacy Times
FEBRUARY 14, 2025
Pharmacists can help patients and their caregivers manage seizures, assess seizure control, and recommend appropriate treatments such as phenobarbital or rescue medications.
Can you skip placebo pills on Slynd?
The Checkup by Singlecare
FEBRUARY 14, 2025
Slynd is a progestin-only, estrogen-free hormonal contraceptive that prevents pregnancy primarily by suppressing ovulation. Slynd contains 24 active hormone pills and four placebo pills, for a total of 28 tablets. According to James Lyons, MD, Physician at Synergy Houses, some people notice lighter or less frequent bleeding on Slynd, but the placebo phase helps create a pattern that can feel more predictable and manageable.
Semaglutide Does Not Increase Depression or Suicidal Ideation Risk in Adults With Overweight, Obesity
Pharmacy Times
FEBRUARY 14, 2025
Treatment with 2.4 mg of semaglutide did not increase the risk of developing suicidal ideation or behavior compared with placebo.
DMD market expected to grow to $5.2bn in the 7MM by 2033
Pharmaceutical Technology
FEBRUARY 14, 2025
The Duchenne muscular dystrophy (DMD) landscape across the seven major markets (7MM) - the US, France, Germany, Italy, Spain, the UK, and Japan - is projected to experience significant growth, with sales increasing from $2.3bn in 2023 to $5.2bn by 2033, according to leading data and analytics company GlobalData.
As Nonopioid Alternatives for Pain Management Emerge, Pharmacists Prove Essential
Pharmacy Times
FEBRUARY 14, 2025
Therapies like the newly approved suzetrigine, a nonopioid NaV1.8 pain signal inhibitor, could revolutionize pain management and mitigate the risks associated with opioid use.
Galderma enters fierce European atopic dermatitis market with Nemluvio approval
Pharmaceutical Technology
FEBRUARY 14, 2025
Nemluvio, which was also approved for prurigo nodularis, becomes Galdermas first approved biologic in its dermatology arsenal.
Let's personalize your content